The Case for Simulating Pregnancy
孕妇通常被排除在药物临床试验之外，这使得临床医生缺乏用药剂量的指导。Discover how…
Certara2026 年 6 月 9 日
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-Bodnar2026 年 5 月 28 日
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators
Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…
Certara2026 年 5 月 26 日
How to Leverage PBPK Modeling and Simulation in Drug Research and Development
Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…
Certara2026 年 5 月 12 日
PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials
The FDA is shifting toward approving drugs based on a single pivotal trial supported by…
Certara2026 年 5 月 12 日
The one-trial era: what the FDA’s shift signals for the future of drug development
The FDA is shifting toward approving drugs based on a single pivotal trial supported by…
Certara2026 年 5 月 6 日
How pharma can transition to non-animal studies for investigational drugs
Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…
Certara2026 年 5 月 5 日
